Evidence map›Paper›PMID 40202832›Full record

ArticleMolecular biology of the cell2025

A morphology and secretome map of pyroptosis.

Michael J Lippincott, Jenna Tomkinson, Dave Bunten, Milad Mohammadi, Johanna Kastl, Johannes Knop, Ralf Schwandner, Jiamin Huang, Grant Ongo, Nathaniel Robichaud and 6 more

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Michael J LippincottDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO 80045.
Jenna TomkinsonDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO 80045.
Dave BuntenDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO 80045.
Milad MohammadiAssay.Works GmbH, Regensburg, Germany 93053.
Johanna KastlAssay.Works GmbH, Regensburg, Germany 93053.
Johannes KnopAssay.Works GmbH, Regensburg, Germany 93053.
Ralf SchwandnerAssay.Works GmbH, Regensburg, Germany 93053.
Jiamin HuangNomic Bio, Montreal, Québec, Canada H2T 1C1.
Grant OngoNomic Bio, Montreal, Québec, Canada H2T 1C1.
Nathaniel RobichaudNomic Bio, Montreal, Québec, Canada H2T 1C1.
Milad DagherNomic Bio, Montreal, Québec, Canada H2T 1C1.
Andrés Mansilla-SotoHealth Sciences Department, University of Aysén, Coyhaique, Chile.
Cynthia Saravia-EstradaHealth Sciences Department, University of Aysén, Coyhaique, Chile.
Masafumi TsuboiDepartment of Chemistry and Biotechnology, University of Tokyo, Tokyo, Japan 113-0033.
Carla Basualto-AlarcónHealth Sciences Department, University of Aysén, Coyhaique, Chile.
Gregory P WayDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO 80045.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyroptosis represents one type of programmed cell death. It is a form of inflammatory cell death that is canonically defined by caspase-1 cleavage and Gasdermin-mediated membrane pore formation. Caspase-1 initiates the inflammatory response (through IL-1β processing), and the N-terminal cleaved fragment of Gasdermin D polymerizes at the cell periphery forming pores to secrete proinflammatory markers. Cell morphology also changes in pyroptosis, with nuclear condensation and membrane rupture. However, recent research challenges canon, revealing a more complex secretome and morphological response in pyroptosis, including overlapping molecular characterization with other forms of cell death, such as apoptosis. Here, we take a multimodal, systems biology approach to characterize pyroptosis. We treated human peripheral blood mononuclear cells (PBMCs) with 36 different combinations of stimuli to induce pyroptosis or apoptosis. We applied both secretome profiling (nELISA) and high-content fluorescence microscopy (Cell Painting). To differentiate apoptotic, pyroptotic, and control cells, we used canonical secretome markers and modified our Cell Painting assay to mark the N-terminus of Gasdermin D. We trained hundreds of machine learning (ML) models to reveal intricate morphology signatures of pyroptosis that implicate changes across many different organelles and predict levels of many proinflammatory markers. Overall, our analysis provides a detailed map of pyroptosis which includes overlapping and distinct connections with apoptosis revealed through a mechanistic link between cell morphology and cell secretome.

Indexed as

PyroptosisSecretomeApoptosisCaspase 1GasderminsHumansInterleukin-1betaIntracellular Signaling Peptides and ProteinsLeukocytes, MononuclearPhosphate-Binding ProteinsCaspase 1GasderminsGSDMD protein, humanInterleukin-1betaIntracellular Signaling Peptides and ProteinsPhosphate-Binding Proteins

Identifiers

PMID40202832
PMCPMC12206506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.